©The Author(s) 2020.
World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1325-1335
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1325
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1325
Table 3 Factors associated with postoperative peritoneal cavity metastasis in Borrmann type IV patients
| Variable | PPCM (79) | Non-PPCM (22) | Pearson P value |
| Tumor location | 0.497 | ||
| Upper 1/3–1/2 (U or MU) | 13 | 4 | |
| Lower 1/3–1/2 (M or L or ML) | 41 | 13 | |
| Total (LAU or LMU) | 25 | 5 | |
| Radical degree | 0.107 | ||
| R0 | 28 | 12 | |
| R1+ | 51 | 10 | |
| Gastrectomy type | 0.112 | ||
| Subtotal gastrectomy | 13 | 7 | |
| Total gastrectomy | 66 | 15 | |
| Venous/lymphatic infiltration | 0.416 | ||
| Yes | 50 | 16 | |
| No | 29 | 6 | |
| pT stage | 0.559 | ||
| pT3 | 23 | 5 | |
| pT4 | 56 | 17 | |
| pN stage | 0.005b | ||
| pN0 | 9 | 8 | |
| pN1-3 | 70 | 14 | |
| Chemotherapy | 0.105 | ||
| Yes | 46 | 17 | |
| No | 33 | 5 |
- Citation: Huang HB, Gao ZM, Sun AQ, Liang WT, Li K. Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer. World J Gastrointest Oncol 2020; 12(11): 1325-1335
- URL: https://www.wjgnet.com/1948-5204/full/v12/i11/1325.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i11.1325